Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
99% Purity Peptide 99% Purity Peptide 99% Purity Peptide
99% Purity Peptide 99% Purity Peptide 99% Purity Peptide
  • Home
  • Shop
  • Features
  • Terms and conditions
  • Pages
  • Home
  • Shop
  • Features
  • Terms and conditions
  • Pages
Close

Search

Trending Now:
Retatrutide Tirzepatide Nad+ MOTS-c Liraglutide HGH IGF-1 LR3 GHK-Cu DSIP Bronchogen Kisspeptin-10
  • Weight Loss & Metabolic
  • Longevity & Anti-Aging
  • Aesthetics & Performance
  • Neuroscience & Nootropics
Subscribe
My account
99% Purity Peptide 99% Purity Peptide 99% Purity Peptide
99% Purity Peptide 99% Purity Peptide 99% Purity Peptide
  • Home
  • Shop
  • Features
  • Terms and conditions
  • Pages
  • Home
  • Shop
  • Features
  • Terms and conditions
  • Pages
Close

Search

Trending Now:
Retatrutide Tirzepatide Nad+ MOTS-c Liraglutide HGH IGF-1 LR3 GHK-Cu DSIP Bronchogen Kisspeptin-10
  • Weight Loss & Metabolic
  • Longevity & Anti-Aging
  • Aesthetics & Performance
  • Neuroscience & Nootropics
Subscribe
My account
Home/Aesthetics & Performance/ACE-031 Peptide: Research in Myostatin Inhibition and Muscle Hypertrophy
ace031_visualization
Aesthetics & Performance

ACE-031 Peptide: Research in Myostatin Inhibition and Muscle Hypertrophy

By gruppo di ricerca
October 1, 2025 3 Min Read
0

May 8, 2026

ACE-031 (also known as ACVR2B-Fc) is a soluble fusion protein consisting of the extracellular domain of the activin receptor type IIB (ActRIIB) fused to a human IgG1 Fc fragment. Research indicates that ACE-031 acts as a powerful “decoy” receptor, binding to specific proteins that naturally limit muscle growth—most notably Myostatin (GDF-8). Unlike traditional muscle-building agents, ACE-031 operates by neutralizing the body’s internal “brakes” on muscle development.

Preclinical investigations have positioned ACE-031 as a primary focus in neuromuscular research, demonstrating significant potential for increasing muscle mass and strength in models of muscular dystrophy and age-related muscle loss (sarcopenia).

What is the mechanism by which ACE-031 exerts its effects?

The primary mechanism underlying ACE-031’s action involves the competitive inhibition of the Transforming Growth Factor-beta (TGF-β) superfamily. By circulating in the bloodstream and binding to signaling molecules before they can reach their target cell receptors, ACE-031 prevents the inhibitory signals that stop muscle cell proliferation.

Upon introduction into a research model, ACE-031 appears to:

  1. Neutralize Myostatin: It binds to Myostatin (GDF-8), preventing it from attaching to the ActRIIB receptors on the surface of muscle cells.
  2. Inhibit Activin A: It also sequesters Activin A and other ligands that negatively regulate muscle growth, providing a broader anabolic effect than myostatin antibodies alone.
  3. Promote Hypertrophy: By removing these inhibitory signals, the peptide allows for an increase in protein synthesis and the proliferation of satellite cells, leading to increased muscle fiber size.
  4. Improve Bone Density: Some studies suggest that by modulating the ActRIIB pathway, ACE-031 may also have secondary beneficial effects on bone mineral density.
ace031_decoy_mechanism

How was ACE-031 discovered in research?

ACE-031 was developed by researchers looking for therapeutic interventions for Duchenne Muscular Dystrophy (DMD) and other muscle-wasting diseases. The discovery of the “double-muscling” phenomenon in certain cattle breeds—caused by a natural mutation in the myostatin gene—provided the scientific basis for targeting the ActRIIB receptor.

Scientists engineered ACE-031 as a soluble version of the receptor itself. Instead of trying to modify the gene, they created a “soak” or “decoy” that would absorb the myostatin proteins before they could act on the muscle. This allowed researchers to study the effects of myostatin inhibition in a controlled, dose-dependent manner.

Research Studies on ACE-031 Peptide

ACE-031 and Rapid Muscle Mass Increase

The role of ACE-031 in healthy research models was investigated to determine the speed of muscle tissue accumulation. In early-phase clinical research, even a single dose appeared to result in measurable increases in the cross-sectional area of the thigh muscle within 29 days. Researchers noted that the increase in lean body mass was accompanied by a decrease in fat mass, suggesting a potential metabolic shift.

ACE-031 and Neuromuscular Resilience

This study aimed to investigate the potential for ACE-031 to mitigate muscle atrophy in models of physical inactivity. Results indicated that by maintaining myostatin inhibition, ACE-031 potentially preserved muscle fiber integrity and force-generating capacity even during periods of immobilization. Mechanistically, this suggests that the peptide may act as a protective agent against the degenerative processes of muscle wasting.

Synopsis

The ACE-031 peptide appears to be one of the most potent modulators of muscle homeostasis in current research. By functioning as a decoy receptor for myostatin and activins, it provides a unique mechanism for studying extreme muscle hypertrophy and the reversal of pathological muscle wasting. Further investigations are warranted to fully understand its long-term impact on vascular stability and systemic endocrine balance in scientific research.


NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

Tags:

ACE-031Muscle HypertrophyMyostatin InhibitorPerformance Research
Author

gruppo di ricerca

Follow Me
Other Articles
retatrutide_centered
Previous

Retatrutide Peptide: Research in Triple-Agonist Metabolic Regulation

aod9604_visualization
Next

AOD9604 Peptide: Research in Lipolysis and Cartilage Regeneration

No Comment! Be the first one.

    Leave a Reply Cancel reply

    Your email address will not be published. Required fields are marked *

    Recent Posts

    • Adamax Peptide: Research in Neuroprotection and Cognitive Augmentation
    • Adipotide (FTTP) Peptide: Research in Targeted Adipose Tissue Vasculature
    • AICAR Peptide: Research in Metabolic Activation and Cellular Energy Homeostasis
    • ARA-290 Peptide: Research in Innate Repair and Neuropathic Protection
    • AOD9604 Peptide: Research in Lipolysis and Cartilage Regeneration

    Recent Comments

    No comments to show.

    Archives

    • October 2025
    • September 2025

    Categories

    • Aesthetics & Performance
    • Healing & Tissue Repair
    • Longevity & Anti-Aging
    • Neuroscience & Nootropics
    • Weight Loss & Metabolic

    Categories

    • Cosmetic (8)
    • Growth (19)
    • Metabolic (22)
    • Neuro (11)
    • Repair (15)
    • Support (2)
    • Systemic (8)
    Hi, I'm Alex. I work in API development research and have in-depth knowledge of the medical, peptide, and health fields.
    • X
    • Instagram
    • Facebook
    • YouTube
    Work Experience

    Shenzhen Research Institute

    Peptide development

    2021-present

    Luxora Digital

    API

    2019-2021

    Southern Medical University

    Support Specialist

    2017-2019

    Available for Hire
    Get In Touch

    Recent Posts

    • adamax_visualization
      Adamax Peptide: Research in Neuroprotection and Cognitive Augmentation
      by gruppo di ricerca
      October 1, 2025
    • hmg_vial.
      HMG: Research in Dual Gonadotropin Signaling and Fertility Models
      by gruppo di ricerca
      September 30, 2025
    • hgh_vial
      HGH: Research in Growth Signaling and Cellular Regeneration
      by gruppo di ricerca
      September 30, 2025
    • hexarelin_vial
      Hexarelin Acetate: Research in GH Secretion and Cardioprotection
      by gruppo di ricerca
      October 1, 2025

    search...

    Information

    • About Me
    • My story
    • Awards & Achievement
    • Contact

    Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

    • Facebook
    • X
    • Instagram
    • LinkedIn

    Discover

    • Weight Loss & Metabolic
    • Longevity & Anti-Aging
    • Aesthetics & Performance
    • Neuroscience & Nootropics

    Latest Posts

    • Tirzepatide Peptide: A Dual-Agonist Approach to Metabolic Research and Weight Regulation
      Tirzepatide is a novel, synthetic peptide that research indicates is… Read more: Tirzepatide Peptide: A Dual-Agonist Approach to Metabolic Research and Weight Regulation
    • Retatrutide Peptide: Research in Triple-Agonist Metabolic Regulation
      May 8, 2026 Retatrutide (also known as LY3437943) is an… Read more: Retatrutide Peptide: Research in Triple-Agonist Metabolic Regulation
    • Ipamorelin Peptide: Research in Selective Growth Hormone Stimulation
      May 13, 2026 Ipamorelin is a synthetic pentapeptide ($Aib-His-D-2-Nal-D-Phe-Lys-NH_2$) that… Read more: Ipamorelin Peptide: Research in Selective Growth Hormone Stimulation

    Locate Us

    123 Demo Blvd, Miami, FL 4567, United States
    danielkimeuuk@gmail.com

    Pages

    • BPC-157 Peptide 10mg – Angiogenesis & Gastric Mucosal Integrity Research
    • SS-31 Peptide (Elamipretide) 50mg – Mitochondrial Cardiolipin Stabilization Research
    • HGH (Human Growth Hormone) 36iu – Somatotropic Signaling & Proteostasis Research
    • Tirzepatide 20mg – GIP & GLP-1 Receptor Dual Agonism Research
    • Retatrutide 60mg – High-Purity GIP & GLP-1 Dual Agonist for Metabolic Modeling

    Contact

    Phone

    +44 7591 782646

    Email

    danielkimeuuk@gmail.com

    Location

    Shenzhen University Longhua Bio-industry Innovation Research Institute Base

    Copyright 2026 — 99% Purity Peptide. We are a peptide chemical supplier. Statements on this site have not been evaluated by the FDA. Our products are not for human/animal use and are not intended to diagnose, treat, cure, or prevent any disease. Laboratory/In-Vitro Research Use Only.